Avantor Q1 net sales down 6% to $1.58B; organic decline 2%; adjusted EPS $0.23

Avantor, Inc.

2025-Q1 EPS reported $0.09 revenue$1,581,400,000

Net sales $1,581.4M (-6% reported, -2% organic); net income $64.5M ($0.09 GAAP EPS); adjusted EPS $0.23.
Lab Solutions sales $1,065M (-8% reported, -3% organic); Bioscience Production $516.4M (-1%, flat organic).
Adjusted EBITDA $269.5M (17.0% margin); operating cash flow $109.3M; free cash flow $82.1M.
Cost transformation target raised to $400M gross run-rate savings by exit 2027; full-year outlook updated for policy headwinds.
Management cites reduced demand in Education & Government end market; net leverage 3.2x.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.